HuGE Literature Finder
Records
1
-
23
| Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocrine-related cancer 2022 Aug . Hescot Segolene, Al Ghuzlan Abir, Henry Theophraste, Sheikh Alard Hala, Lamartina Livia, Borget Isabelle, Hadoux Julien, Baudin Eric, Dupuy Corinne, Nikitski Alyaksandr V, Nikiforov Yuri E, Schlumberger Martin, Nikiforova Marina N, Leboulleux Soph |
| Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics. In vivo (Athens, Greece) 2022 1 36 (1): 111-120. Kim Jae-Hui, Jeong Ji Yun, Seo An Na, Park Nora Jee-Young, Kim Moonsik, Park Ji You |
| Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 2021 Feb . Qin Y U, Wang Jennifer Rui, Wang Ying, Iyer Priyanka C, Cote Gilbert, Busaidy Naifa, Dadu Ramona, Zafereo Mark, Williams Michelle D, Ferrarotto Renata, Gunn Brandon, Wei Peng, Patel Keyur, Hofmann Marie-Claude, Cabanillas Mar |
| Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer. The Journal of clinical endocrinology and metabolism 2021 Jan . Zhang Lingyun, Ren Zhixiang, Su Zhengzheng, Liu Yang, Yang Tian, Cao Minyuan, Jiang Yong, Tang Ying, Chen Haining, Zhang Weihan, Gong Rixiang, Wei Tao, Peng Yong, Liu Bo, Zhang Wei, Yang Li, Hu Yiguo, Li Zhihui, Zhu Jingqiang, Xu Heng, Shu Yang, Luo H |
| Risk Stratification Using a Novel Genetic Classifier Including PLEKHS1 Promoter Mutations for Differentiated Thyroid Cancer with Distant Metastasis. Thyroid : official journal of the American Thyroid Association 2020 Apr . Jung Chan Kwon, Jung Seung-Hyun, Jeon Sora, Jeong Young Mun, Kim Yourha, Lee Sohee, Bae Ja-Seong, Chung Yeun-Ju |
| The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features. IUBMB life 2020 Jan . Heidari Zahra, Harati-Sadegh Mahdiyeh, Arian Abtin, Maruei-Milan Rostam, Salimi Saeed |
| Next-generation sequencing identified somatic alterations that may underlie the etiology of Chinese papillary thyroid carcinoma. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019 Nov . Yang Chuanjia, Gong Jian, Xu Weixue, Liu Zhen, Cui Dong |
| Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing. International journal of molecular sciences 2019 Jun 20 (13): . Borowczyk Martyna, Szczepanek-Parulska Ewelina, Debicki Szymon, Budny Bartlomiej, Verburg Frederik A, Filipowicz Dorota, Wieckowska Barbara, Janicka-Jedynska Malgorzata, Gil Lidia, Ziemnicka Katarzyna, Ruchala Mar |
| Mutation profiles of follicular thyroid tumors by targeted sequencing. Diagnostic pathology 2019 May 14 (1): 39. Duan Huanli, Liu Xiaoding, Ren Xinyu, Zhang Hui, Wu Huanwen, Liang Zhiyo |
| Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes. Hereditary cancer in clinical practice 2019 17 5. Henn Jonas, Spier Isabel, Adam Ronja S, Holzapfel Stefanie, Uhlhaas Siegfried, Kayser Katrin, Plotz Guido, Peters Sophia, Aretz Stef |
| Not the same thing: metastatic PTCs have a different background than ATCs. Endocrine connections 2018 Nov . de Biase Dario, Torricelli Federica, Ragazzi Moira, Donati Benedetta, Khun Elisabetta, Visani Michela, Acquaviva Giorgia, Pession Annalisa, Tallini Giovanni, Piana Simonetta, Ciarrocchi Aless |
| Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. Cancer cell 2018 Aug 34 (2): 242-255.e5. Gopal Raj K, Kübler Kirsten, Calvo Sarah E, Polak Paz, Livitz Dimitri, Rosebrock Daniel, Sadow Peter M, Campbell Braidie, Donovan Samuel E, Amin Salma, Gigliotti Benjamin J, Grabarek Zenon, Hess Julian M, Stewart Chip, Braunstein Lior Z, Arndt Peter F, Mordecai Scott, Shih Angela R, Chaves Frances, Zhan Tiannan, Lubitz Carrie C, Kim Jiwoong, Iafrate A John, Wirth Lori, Parangi Sareh, Leshchiner Ignaty, Daniels Gilbert H, Mootha Vamsi K, Dias-Santagata Dora, Getz Gad, McFadden David |
| Diagnostic value and lymph node metastasis prediction of a custom-made panel (thyroline) in thyroid cancer. Oncology reports 2018 Jun . Ke Zunfu, Liu Yihao, Zhang Yunjian, Li Jie, Kuang Ming, Peng Sui, Liang Jinyu, Yu Shuang, Su Lei, Chen Lili, Sun Cong, Li Bin, Cao Jessica, Lv Weiming, Xiao Haipe |
| Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine 2016 Oct . Latteyer Soeren, Tiedje Vera, König Katharina, Ting Saskia, Heukamp Lukas C, Meder Lydia, Schmid Kurt Werner, Führer Dagmar, Moeller Lars Christi |
| Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma. Cancer biomarkers : section A of Disease markers 2016 Jun . Halkova Tereza, Dvorakova Sarka, Sykorova Vlasta, Vaclavikova Eliska, Vcelak Josef, Vlcek Petr, Sykorova Pavla, Kodetova Daniela, Betka Jan, Lastuvka Petr, Bavor Petr, Hoch Jiri, Katra Rami, Bendlova Be |
| Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area. Thyroid : official journal of the American Thyroid Association 2016 05 26 (5): 683-90. Jeon Min Ji, Chun Sung-Min, Kim Deokhoon, Kwon Hyemi, Jang Eun Kyung, Kim Tae Yong, Kim Won Bae, Shong Young Kee, Jang Se Jin, Song Dong Eun, Kim Won |
| Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer. Cancer biomarkers : section A of Disease markers 2015 Jun 15 (4): 459-65. Khan Mosin S, Pandith Arshad A, Masoodi Shariq R, Khan Shoukat H, Rather Tanveer A, Andrabi Khursid I, Mudassar Sy |
| A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors. BMC cancer 2015 15 157. Evangelisti Cecilia, de Biase Dario, Kurelac Ivana, Ceccarelli Claudio, Prokisch Holger, Meitinger Thomas, Caria Paola, Vanni Roberta, Romeo Giovanni, Tallini Giovanni, Gasparre Giuseppe, Bonora Ele |
| The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population. Asian Pacific journal of cancer prevention : APJCP 2015 16 (7): 3073-7. Dehghan Roghayeh, Hosseinpour Feizi Mohammad Ali, Pouladi Nasser, Adampourezare Mina, Farajzadeh Davo |
| Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. European journal of endocrinology / European Federation of Endocrine Societies 2012 Feb 166 (2): 241-5. Barbieri R B, Bufalo N E, Secolin R, Silva A C N, Assumpção L V M, Maciel R M B, Cerutti J M, Ward L |
| Involvement of CYP1A1, GST, 72TP53 polymorphisms in the pathogenesis of thyroid nodules. Genetics and molecular research : GMR 2010 9 (4): 2222-9. Reis A A S, Silva D M, Curado M P, da Cruz A |
| RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. Journal of endocrinological investigation 2008 Oct 31 (10): 893-9. Siraj A K, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O, Uddin S, Al-Kuraya |
| TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncology reports 2006 Apr 15 (4): 949-56. Rogounovitch Tatiana I, Saenko Vladimir A, Ashizawa Kiyoto, Sedliarou Ilya A, Namba Hiroyuki, Abrosimov Aleksandr Yu, Lushnikov Eugeny F, Roumiantsev Pavel O, Konova Marina V, Petoukhova Natalia S, Tchebotareva Irina V, Ivanov Viktor K, Chekin Sergei Yu, Bogdanova Tatiana I, Tronko Mykola D, Tsyb Anatoly F, Thomas Gerry A, Yamashita Shunic |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: